Clinical Trial

The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management

Study acronym: PRECEDE
Recruiting
View on ClinicalTrials.gov →
Summary
This is a multi-center, prospective, and interventional study conducted in 3 types of cardiovascular diseases (CVD) participants , including 3 cohorts which are patients with newly or previously diagnosed coronary heart disease ( CHD), atrial fibrillation ( AF) and chronic heart failure (CHF).
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-05-23
notable Trial sites expanded: 69 -> 84 locations 2026-04-21
Trial Details
NCT Number NCT06909773
Lead Sponsor AstraZeneca
Conditions Cardiovascular Diseases
Enrollment 3,000 participants
Start Date 2025-11-28
Primary Completion 2026-10-28 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-26